In the name of competition, the European Commission wants to stop the US DNA sequencing company from buying a US leader in applying DNA sequencing to novel cancer diagnostics. The view from the ground in Europe is that it may not matter so much
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.